In Regard to Laughlin et al.

Laughlin et al1 highlight the longitudinal toxicity and cosmesis as assessed by physicians and patients for moderately hypofractionated (MHF) and ultrahypofractionated (UHF) regimens. The trial's primary outcome was the complication rate at 24 months. Complications were defined as clinician-reported grade 3 toxicity or higher through the Common Terminology Criteria for Adverse Events (CTCAE) scale or worsening of clinician-reported cosmesis through the Harvard Cosmesis scale. Low rates of toxicity and excellent/good cosmesis were reported in both arms by clinicians and the conclusion was UHF had similar treatment-related effects in comparison to MHF.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Letters to the Editor Source Type: research